SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: IMW who wrote (6)2/6/1998 10:05:00 AM
From: James Reynolds  Read Replies (1) of 447
 
IMW

I understand the latest patent is due to be issued Q1 98. This is a very broad and potentially valuable addition to their patent portfolio and may trigger some licensing activity.

I cannot account for the current weakness except for a possible enforced sale by a large holder. All recent news has been very positive. AHP took up their option on the diabetes compound, Anaderm is progressing well, so too is Helicon.

In terms of drug discovery capability, OSIP appears to go from strength to strength.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News